Aurinia Pharmaceuticals Inc

AUPH NASDAQ Healthcare & Biotech United States CA05156V1022
15.40 $
0.52 %

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies to treat autoimmune diseases.